Profile | GDS2987 / GI_19923361-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 3.4 | 12 |
GSM215254 | HMVEC_atorvastatin_rep1 | 10.9 | 29 |
GSM215282 | HMVEC_atorvastatin_rep3 | 10.8 | 25 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 1135.7 | 94 |
GSM215298 | PASMC_vehicle_rep2 | 1196.3 | 94 |
GSM215310 | PASMC_vehicle_rep3 | 1019.2 | 94 |
GSM215311 | PASMC_atorvastatin_rep1 | 822 | 93 |
GSM215312 | PASMC_atorvastatin_rep2 | 757.8 | 92 |
GSM215313 | PASMC_atorvastatin_rep3 | 833.3 | 92 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 935.8 | 93 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 1001.2 | 93 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 940.7 | 93 |
GSM215327 | PASMC_SLx2119_rep1 | 504.2 | 89 |
GSM215328 | PASMC_SLx2119_rep2 | 550.4 | 90 |
GSM215329 | PASMC_SLx2119_rep3 | 507.4 | 89 |
GSM215330 | Fibroblasts_vehicle_rep1 | 131.9 | 78 |
GSM215331 | Fibroblasts_vehicle_rep2 | 144.2 | 78 |
GSM215332 | Fibroblasts_vehicle_rep3 | 195.6 | 82 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 135.1 | 78 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 157.7 | 79 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 136.4 | 78 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 134 | 78 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 188.2 | 81 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 143.6 | 78 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 132.1 | 77 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 176 | 80 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 190.4 | 81 |